Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors
- PMID: 27508189
- PMCID: PMC4918279
- DOI: 10.2147/JHC.S73828
Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors
Abstract
Background: Hepatocellular carcinoma (HCC) is a common cancer worldwide as well as in Egypt with hepatitis C and B, alcohol and aflatoxins being the commonest risk factors.
Aim: The objective of this study was to assess the prognostic factors affecting overall survival (OS) of untreated HCC in Egypt.
Methods: This retrospective study was conducted at Tanta Cancer Center, Egypt where 288 HCC cases who received no specific therapy and were followed-up until death were identified. The impact of possible prognostic factors on OS was assessed using the log-rank test (univariate analyses) and Cox regression method (multivariate analysis).
Results: The median OS of untreated HCC was 2.3 months (95% confidence interval: 1.9-2.6). The 1, 3, 6, 12, 24 months OS rates were 84%, 42%, 21%, 9%, and 3%, respectively. All cases had died by 46 months. Male sex, advanced Child-Pugh class, the clinical presentation of ascites, cough, fatigue, and the presence of metastases were associated with poor survival (P<0.05 for all). In multivariate analysis; cough, presence of ascites, and Child-Pugh class were independent predictors of poor survival.
Conclusion: OS in untreated HCC in Egypt is very short. Many factors interact to produce this dismal survival.
Keywords: Egypt; hepatocellular carcinoma; prognosis; survival.
Figures
References
-
- globocan.iarc.fr [homepage on the Internet] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 10. Lyon, France: IARC; 2010. [Accessed October 16, 2014]. GLOBOCAN 2008 v1.2. Available from: http://globocan.iarc.fr.
-
- Ahmad J, Rabinovitz M. In: Etiology and Epidemiology of Hepatocellular Carcinoma in Current Clinical Oncology: Hepatocellular Cancer: Diagnosis and Treatment. Carr I, editor. Totowa: Humana Press Inc; 2005. pp. 1–22.
-
- Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19(3):271–285. - PubMed
-
- Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol. 1999;31(Suppl 1):17–24. - PubMed
LinkOut - more resources
Full Text Sources
